C5β, or complement component 5 beta, plays a pivotal role in the activation and regulation of the complement system, a crucial component of the innate immune response. The complement system functions as a rapid and efficient defense mechanism against pathogens and foreign invaders, as well as in the clearance of immune complexes and apoptotic cells. C5β is a fragment generated from the proteolytic cleavage of the complement protein C5, which occurs as part of the complement activation cascade. Upon activation, C5 is cleaved into two fragments, C5α and C5β, with C5β being essential for the formation of the membrane attack complex (MAC), also known as the C5b-9 complex. The MAC is a pore-forming structure that inserts into target cell membranes, leading to osmotic lysis and cell death, particularly of bacterial pathogens.
The activation of C5β occurs through a series of proteolytic cleavage events within the complement cascade, initiated by the recognition and binding of specific pattern recognition molecules to target surfaces. This triggers a cascade of enzymatic reactions involving complement proteins, resulting in the sequential cleavage and activation of C5. Once C5 is activated, it undergoes conformational changes that expose cleavage sites, allowing for the generation of C5β. Subsequently, C5β associates with other complement components, including C6, C7, C8, and C9, to form the MAC complex. The assembly of the MAC on target cell membranes leads to pore formation and subsequent cell lysis, contributing to the elimination of pathogens and infected cells. Overall, the activation of C5β represents a critical step in the complement cascade, essential for the initiation of the MAC-mediated immune response and host defense mechanisms.
Items 11 to 18 of 18 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin free acid activates C5β by inducing calcium ion influx into the cytoplasm, triggering downstream signaling cascades that culminate in the activation of C5β. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 activates C5β indirectly by inhibiting phosphoinositide 3-kinase (PI3K), leading to modulation of downstream pathways involved in C5β activation, albeit through an indirect mechanism. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that can indirectly activate C5β by promoting calcium influx, a crucial step in the complement activation cascade. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram activates C5β indirectly by inhibiting phosphodiesterase 4 (PDE4), leading to elevated levels of cAMP, which in turn activates protein kinase A, ultimately resulting in C5β activation. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is an immune response modifier that can indirectly activate C5β by stimulating immune cells and cytokine production, contributing to complement system activation. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly I:C is a synthetic analog of double-stranded RNA that can indirectly activate C5β by triggering an immune response involving pattern recognition receptors. | ||||||
Lipoteichoic acid | 56411-57-5 | sc-507479 | 5 mg | $248.00 | ||
Lipoteichoic acid is a component of the cell wall in Gram-positive bacteria. Its interaction with the immune system can lead to complement system activation, including C5β. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast activates C5β by inhibiting phosphodiesterase 5 (PDE5), leading to elevated levels of cGMP, which modulates downstream signaling pathways that converge on C5β, promoting its activation. | ||||||